Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Iron overload reduces synthesis and elimination of bile acids in rat liver

A. Prasnicka, H. Lastuvkova, F. Alaei Faradonbeh, J. Cermanova, M. Hroch, J. Mokry, E. Dolezelova, P. Pavek, K. Zizalova, L. Vitek, P. Nachtigal, S. Micuda,

. 2019 ; 9 (1) : 9780. [pub] 20190705

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028880

Excessive iron accumulation in the liver, which accompanies certain genetic or metabolic diseases, impairs bile acids (BA) synthesis, but the influence of iron on the complex process of BA homeostasis is unknown. Thus, we evaluated the effect of iron overload (IO) on BA turnover in rats. Compared with control rats, IO (8 intraperitoneal doses of 100 mg/kg every other day) significantly decreased bile flow as a consequence of decreased biliary BA secretion. This decrease was associated with reduced expression of Cyp7a1, the rate limiting enzyme in the conversion of cholesterol to BA, and decreased expression of Bsep, the transporter responsible for BA efflux into bile. However, IO did not change net BA content in faeces in response to increased intestinal conversion of BA into hyodeoxycholic acid. In addition, IO increased plasma cholesterol concentrations, which corresponded with reduced Cyp7a1 expression and increased expression of Hmgcr, the rate-limiting enzyme in de novo cholesterol synthesis. In summary, this study describes the mechanisms impairing synthesis, biliary secretion and intestinal processing of BA during IO. Altered elimination pathways for BA and cholesterol may interfere with the pathophysiology of liver damage accompanying liver diseases with excessive iron deposition.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028880
003      
CZ-PrNML
005      
20210114155255.0
007      
ta
008      
210105s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-019-46150-7 $2 doi
035    __
$a (PubMed)31278332
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Prasnicka, Alena $u Department of Pharmacology, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic. Department of Biological and Medical Sciences, Charles University, Faculty of Pharmacy in Hradec Kralove, Hradec Kralove, Czech Republic.
245    10
$a Iron overload reduces synthesis and elimination of bile acids in rat liver / $c A. Prasnicka, H. Lastuvkova, F. Alaei Faradonbeh, J. Cermanova, M. Hroch, J. Mokry, E. Dolezelova, P. Pavek, K. Zizalova, L. Vitek, P. Nachtigal, S. Micuda,
520    9_
$a Excessive iron accumulation in the liver, which accompanies certain genetic or metabolic diseases, impairs bile acids (BA) synthesis, but the influence of iron on the complex process of BA homeostasis is unknown. Thus, we evaluated the effect of iron overload (IO) on BA turnover in rats. Compared with control rats, IO (8 intraperitoneal doses of 100 mg/kg every other day) significantly decreased bile flow as a consequence of decreased biliary BA secretion. This decrease was associated with reduced expression of Cyp7a1, the rate limiting enzyme in the conversion of cholesterol to BA, and decreased expression of Bsep, the transporter responsible for BA efflux into bile. However, IO did not change net BA content in faeces in response to increased intestinal conversion of BA into hyodeoxycholic acid. In addition, IO increased plasma cholesterol concentrations, which corresponded with reduced Cyp7a1 expression and increased expression of Hmgcr, the rate-limiting enzyme in de novo cholesterol synthesis. In summary, this study describes the mechanisms impairing synthesis, biliary secretion and intestinal processing of BA during IO. Altered elimination pathways for BA and cholesterol may interfere with the pathophysiology of liver damage accompanying liver diseases with excessive iron deposition.
650    _2
$a zvířata $7 D000818
650    _2
$a žlučové kyseliny a soli $x metabolismus $7 D001647
650    _2
$a biologické markery $7 D015415
650    _2
$a cholesterol $x metabolismus $7 D002784
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a exprese genu $7 D015870
650    _2
$a přetížení železem $x etiologie $x metabolismus $x patologie $7 D019190
650    _2
$a játra $x metabolismus $x patologie $7 D008099
650    _2
$a oxidační stres $7 D018384
650    _2
$a messenger RNA $x genetika $x metabolismus $7 D012333
650    _2
$a krysa rodu Rattus $7 D051381
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Lastuvkova, Hana $u Department of Pharmacology, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Alaei Faradonbeh, Fatemeh $u Department of Pharmacology, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Cermanova, Jolana $u Department of Pharmacology, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Hroch, Milos $u Department of Medical Biochemistry, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Mokry, Jaroslav $u Department of Histology and Embryology, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Dolezelova, Eva $u Department of Biological and Medical Sciences, Charles University, Faculty of Pharmacy in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Pavek, Petr $u Department of Pharmacology and Toxicology, Charles University, Faculty of Pharmacy in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Zizalova, Katerina $u Department of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Vitek, Libor $u Department of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Nachtigal, Petr $u Department of Biological and Medical Sciences, Charles University, Faculty of Pharmacy in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Micuda, Stanislav $u Department of Pharmacology, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic. micuda@lfhk.cuni.cz.
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 9, č. 1 (2019), s. 9780
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31278332 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114155253 $b ABA008
999    __
$a ok $b bmc $g 1609215 $s 1120060
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 9 $c 1 $d 9780 $e 20190705 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...